The modification of invariant Ser residues in acyl carrier proteins (ACPs) by transfer of a 4-phosphopantetheine moiety is essential to all living organisms. The reactions is carried out by a diverse group of enzymes collectively characterized as 4-phosphopantetheine transferases (PPTases), also known as holo-ACP synthases, yielding holo-carrier proteins by group transfer of the 4-phosphopantetheine moiety from coenzyme A (CoA) as donor substrate. Recent molecular cloning and biochemical characterization of human PPTase revealed that it is a cytosolic, monomeric enzyme with broad acceptor substrate specificity, and requires Mg 2+ for catalysis. In order to better understand its mode of action, human PPTase was crystallised and structures of the enzyme, its complex with CoA, and in complex with CoA and cytosolic fatty acid synthase (FAS) ACP were determined. The enzyme, which adopts the same fold observed in bacterial group II PPTases, consists of two nearly identical domains with the active site located in a deep cleft between the domains. ACP binds with its essential Ser pointing towards the bound CoA, interacts with the enzyme on a large surface and is positioned primarily by hydrophobic forces. CoA-binding is mediated by a Mg 2+ ion complexed by Glu residues. Mutagenesis studies indicate that in addition to the residues involved in Mg 2+ -binding, a base catalyst Lys and a His are essential for catalysis. Although the shape of FAS ACP is complementary to the large basin on the enzyme near the active site, there are still features on the binding surface not explained by the ternary complex. It is tempting to speculate that these regions play a role in binding mitochondrial ACP, since it has been demonstrated that human PPTase can activate ACP from the mitochondrial fatty acid synthesis machinery as well. Progress on establishing the structure of this complex will also be reported. Keywords: protein crystallography, flavoproteins, molecular modelling IDI-2 is an essential enzyme for those pathogenic microorganisms, such as some strains of Streptococcus and Staphylococcus. [1] Thus, IDI-2 is a logical target for the design of antiinfectious agents. The catalytic mechanism of the enzyme remains unknown. A crystal structure of the B. subtilis protein was solved in 2003. [2] However, electron density was not detected for several amino acids at the active site due to its conformational flexibility. In the present work, we obtained some small yellow crystals which belonged to orthorhombic P2 1 2 1 2 1 space group and diffracted to 2.8 Å at the ESRF, Grenoble, France. Crystal structures of T. thermophilus and B. subtilis type 2 IPP isomerases were, then, combined to generate a complete model of the FMN-bound structure of the enzyme. In contrast to previous studies, positions of flexible loops were obtained and carefully analyzed by molecular dynamics. Docking simulations find a unique putative binding site for the IPP substrate. [3] 
